Foreword |
|
ix | |
|
|
|
|
Pathogenesis of IgA Nephropathy |
|
|
1 | (7) |
|
|
Treatment for IgA Nephropathy |
|
|
8 | (5) |
|
|
Clinical Reviews of IgA Nephropathy |
|
|
|
International IgA Nephropathy Network Clinico-Pathological Classification of IgA Nephropathy |
|
|
13 | (6) |
|
|
|
|
|
|
IgA Nephropathy: A Clinical Overview |
|
|
19 | (8) |
|
|
|
|
|
|
|
Angiotensin Antagonists and Fish Oil for Treating IgA Nephropathy |
|
|
27 | (10) |
|
|
|
|
|
|
Treatment of IgA Nephropathy: Corticosteroids, Tonsillectomy, and Mycophenolate Mofetil |
|
|
37 | (7) |
|
|
Interpretation of Renal Biopsies in IgA Nephropathy |
|
|
44 | (6) |
|
|
Basic Reviews of IgA Nephropathy |
|
|
|
Altered Expression of Lymphocyte Homing Chemokines in the Pathogenesis of IgA Nephropathy |
|
|
50 | (6) |
|
|
|
|
|
|
IgA Nephropathy: Current Views of Immune Complex Formation |
|
|
56 | (8) |
|
|
|
|
|
|
|
|
|
Pathogenic Role of IgA Receptors in IgA Nephropathy |
|
|
64 | (6) |
|
|
The Mucosa-Bone-Marrow Axis in IgA Nephropathy |
|
|
70 | (10) |
|
|
|
Searching for IgA Nephropathy Candidate Genes: Genetic Studies Combined with High Throughput Innovative Investigations |
|
|
80 | (10) |
|
|
|
|
|
|
|
|
|
|
|
Clinical Advances (Update) |
|
|
|
Clinicopathological Influence of Obesity in IgA Nephropathy: Comparative Study of 74 Patients |
|
|
90 | (4) |
|
|
|
|
|
|
|
|
|
|
|
A Multicenter Prospective Cohort Study of Tonsillectomy and Steroid Therapy in Japanese Patients with IgA Nephropathy: A 5-Year Report |
|
|
94 | (5) |
|
|
|
|
|
|
|
|
Tonsillectomy and Corticosteroid Therapy with Concomitant Methylprednisolone Pulse Therapy for IgA Nephropathy |
|
|
99 | (5) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Impact of Annual Urine Health Check-Up System to Obtain Clinical Remission in Patients with IgA Nephropathy |
|
|
104 | (5) |
|
|
|
|
Sequential Immunosuppressive Therapy in Progressive IgA Nephropathy |
|
|
109 | (5) |
|
|
|
|
|
|
Prospective Trial of Combined Therapy with Heparin/Warfarin and Renin-Angiotensin System Inhibitors in Progressive IgA Nephropathy |
|
|
114 | (6) |
|
|
|
|
|
|
|
|
|
Downregulation of the β1,3-Galactosyltransferase Gene in Tonsillar B Lymphocytes and Aberrant Lectin Bindings to Tonsillar IgA as a Pathogenesis of IgA Nephropathy |
|
|
120 | (5) |
|
|
|
|
|
|
|
|
|
|
|
Development of IgA Nephropathy-Like Disease with High Serum IgA Levels and Increased Proportion of Polymeric IgA in β1,4-Galactosyltransferase-Deficient Mice |
|
|
125 | (4) |
|
|
|
|
|
|
|
|
|
|
|
IgA Nephropathy: Characterization of IgG Antibodies Specific for Galactose-Deficient IgA1 |
|
|
129 | (5) |
|
|
|
|
|
|
|
|
|
|
|
IgA Nephropathy and Henoch-Schoenlein Purpura Nephritis: Aberrant Glycosylation of IgA1, Formation of IgA1-Containing Immune Complexes, and Activation of Mesangial Cells |
|
|
134 | (5) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Patients with IgA Nephropathy Respond Strongly Through Production of IgA with Low Avidity Against Staphylococcus aureus |
|
|
139 | (5) |
|
|
|
|
|
|
|
|
Transferrin Receptor Engagement by Polymeric IgA1 Induces Receptor Expression and Mesangial Cell Proliferation: Role in IgA Nephropathy |
|
|
144 | (4) |
|
|
|
|
|
|
|
|
|
IgA Fc Receptor I Is a Molecular Switch that Determines IgA Activating or Inhibitory Functions |
|
|
148 | (5) |
|
|
|
|
The Role of PDGF-D in Mesangioproliferative Glomerulonephritis |
|
|
153 | (6) |
|
|
|
|
|
Analysis of Innate Immune Responses in a Model of IgA Nephropathy Induced by Sendai Virus |
|
|
159 | (5) |
|
|
|
|
|
|
|
|
Roles of Bone Marrow, Mucosa and Lymphoid Tissues in Pathogenesis of Murine IgA Nephropathy |
|
|
164 | (5) |
|
|
|
|
|
|
|
|
|
|
169 | (75) |
|
|
|
|
Clinical Reviews of IgA Nephropathy |
|
|
174 | (6) |
|
Basic Reviews of IgA Nephropathy |
|
|
180 | (5) |
|
Clinical Advances (Update) |
|
|
185 | (30) |
|
|
215 | (28) |
|
|
243 | (1) |
Author Index |
|
244 | (5) |
Subject Index |
|
249 | |